Salvianolic acid B inhibits oxidative damage of bone marrow mesenchymal stem cells and promotes differentiation into cardiomyocytes

doi:10.3969/j.issn.2095-4344.2168

Abstract

Abstract: BACKGROUND: In recent years, bone marrow mesenchymal stem cells have been used in clinical treatment of heart injury caused by permanent cardiomyocytopenia. However, the best inducer to promote the proliferation and differentiation of bone marrow mesenchymal stem cells into cardiomyocytes is still in the research and selection.
OBJECTIVE: To investigate the protective effect of salvianolic acid B on oxidative stress injury and cardiomyocyte differentiation of bone marrow mesenchymal stem cells.
METHODS: Bone marrow mesenchymal stem cells were used as study objects to establish oxidative stress injury model by 300 μmol/L H2O2 for 24 hours. Simultaneously, bone marrow mesenchymal stem cells were treated with salvianolic acid B for 24 hours. The contents of lactate dehydrogenase and creatine kinase in the supernatant and malondialdehyde and superoxide dismutase in the cell lysate were determined in each group using the kit. Western blot assay was used to detect the expression of nuclear factor E2 related factor 2 (Nrf2), Keap1, Bcl-2 and Bax in bone marrow mesenchymal stem cells. RT-PCT was used to detect cardiomyocyte differentiation-related markers 14 days after intervention.
RESULTS AND CONCLUSION: (1) Compared with the model group, the levels of lactate dehydrogenase and creatine kinase in the supernatant were significantly decreased in the salvianolic acid B group (P < 0.05). (2) Compared with the model group, the level of malondialdehyde in cell lysate was decreased, and the level of superoxide dismutase was increased in the salvianolic acid B group (P < 0.05). (3) Compared with the model group, expression of Nrf2 protein in cells was significantly increased, and the expression of Keap1 protein was significantly decreased in the salvianolic acid B group. (4) The expression of Bcl-2 in salvianolic acid B group was significantly higher than that in model group, and the expression of Bax in salvianolic acid B group was significantly lower than that in model group. (5) Compared with the model group, the expression of GATA4 and cTnT mRNA was significantly increased in the salvianolic acid B group. (6) Salvianolic acid B can induce the expression of proteins that activate Nrf2-ARE signaling pathway in bone marrow mesenchymal stem cells for anti-oxidation, and salvianolic acid B can inhibit apoptosis and improve the ability of bone marrow mesenchymal stem cells to differentiate into cardiomyocytes.

Key words: stem cells, bone marrow mesenchymal stem cells, salvianolic acid B, cardiomyocytes, oxidative stress, apoptosis, pathway

CLC Number:

Pei Lili, Sun Guicai, Wang Di. Salvianolic acid B inhibits oxidative damage of bone marrow mesenchymal stem cells and promotes differentiation into cardiomyocytes[J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1032-1036.

Figures/Tables 7

References

[1] ULLAH I, SUBBARAO RB, RHO GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
[2] KLIMCZAK A, KOZLOWSKA U. Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis. Stem Cells Int. 2016;2016:4285215.
[3] 刘建和,赵吉锐,雷娄芳,等.柴胡三参胶囊对p38MAPK通路介导BMSCs向心肌细胞分化的干预研究[J].中国中医急症,2018,27(7): 1163-1166,1170.
[4] 贺继刚,韩金秀,严丹,等.过表达GATA-4骨髓间充质干细胞以外泌体修复心肌损伤的相关microRNA[J].中国组织工程研究,2018, 22(21):3292-3298.
[5] GAO Q, GUO M, JIANG X, et al. A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells. Stem Cells Int. 2014;2014:162024.
[6] DENG Y, ZHANG T, TENG F, et al. Ginsenoside Rg1 and Rb1, in combination with salvianolic acid B, play different roles in myocardial infarction in rats. J Chin Med Assoc. 2015;78(2):114-120.
[7] 顾娟.丹参中酚酸类物质的提取与纯化[D].成都:成都理工大学, 2006.
[8] 陈雪,沈楠,安英.丹酚酸B对氧化应激损伤乳鼠心肌细胞的保护作用及其机制[J].吉林大学学报(医学版),2018,44(5):974-978.
[9] 刘莎莎,张赛,汤智,等.丹酚酸B对缺氧复氧诱导H9c2心肌细胞损伤的保护作用机制研究[J].湖南中医药大学学报,2017,37(8): 832-837.
[10] LV Y, GAO CW, LIU B, et al. BMP-2 combined with salvianolic acid B promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Kaohsiung J Med Sci. 2017;33(10):477-485.
[11] 杨雷,郭青榜,卢艳.槲皮素对过氧化氢所致体外心肌细胞损伤的保护作用[J].中国临床康复,2006,10(3):60-62.
[12] 陈裕浩,朱向情,潘兴华.骨髓间充质干细胞的衰老特征及其与治疗的相关性[J].中国组织工程研究,2017,21(17): 2746-2752.
[13] SUN T, YU HY, ZHANG CL, et al. Respiratory syncytial virus infection up-regulates TLR7 expression by inducing oxidative stress via the Nrf2/ARE pathway in A549 cells. Arch Virol. 2018;163(5):1209-1217.
[14] HU R, SAW CL, YU R, et al. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid Redox Signal. 2010;13(11):1679-1698.
[15] 刘薇,王红霞,王立魁,等.COX-2/Nrf2/ARE信号通路与体内外的抗炎、抗氧化作用机理[J].生命科学,2011,23(10): 1027-1033.
[16] BAIRD L, DINKOVA-KOSTOVA AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85(4):241-272.
[17] KALOGERIS T, BAO Y, KORTHUIS RJ. Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2014;2:702-714.
[18] KOHEN R, NYSKA A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30(6):620-650.
[19] EL-AWADYEL SE, MOUSTAFA YM, ABO-ELMATTY DM, et al. Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies. Eur J Pharmacol. 2011;650(1):335-341.
[20] HE JG, LI HR, LI BB, et al. Bone marrow mesenchymal stem cells overexpressing GATA-4 improve cardiac function following myocardial infarction. Perfusion. 2019;34(8):696-704.
[21] MARKMEE R, AUNGSUCHAWAN S, POTHACHAROEN P,et al. Effect of ascorbic acid on differentiation of human amniotic fluid mesenchymal stem cells into cardiomyocyte-like cells. Heliyon. 2019;5(7):e02018.
[22] IBARRA-IBARRA BR, FRANCO M, PAEZ A, et al. Improved Efficiency of Cardiomyocyte-Like Cell Differentiation from Rat Adipose Tissue-Derived Mesenchymal Stem Cells with a Directed Differentiation Protocol. Stem Cells Int. 2019;2019:8940365.
[23] TRIPATHY NK, RIZVI SHM, SINGH SP, et al. Cardiomyogenic Heterogeneity of Clonal Subpopulations of Human Bone Marrow Mesenchymal Stem Cells. J Stem Cells Regen Med. 2018;14(1):27-33.